Older age is the main risk factor for cancer. This largely reflects cell DNA damage accumulating over time. Damage can result from biological processes or from exposure to risk factors.
This page covers other factors with the best evidence of an association with cancer risk; this list is not exhaustive.
See our other pages for general information about cancer, or ways to reduce your risk.
View our latest cancer statistics including key stats, in-depth explanations and raw data on cancer incidence, mortality, survival, risk, and diagnosis and treatment.
View full A-Z cancer statisticsSee information and explanations on terminology used for statistics and reporting of cancer, and the methods used to calculate some of our statistics.
Go to local cancer statistics - search profiles by area, constituency or health board in the UK.
Go to devolved nations overview for an overview of Wales, Scotland or Northern Ireland.
You are welcome to reuse this Cancer Research UK content for your own work. Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:
Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.
When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research. Send a cheque payable to Cancer Research UK to: Cancer Research UK, 2 Redman Place, London, E20 1JQ.
Donate onlineStay up to date by signing up to our cancer statistics and intelligence newsletter.
We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used.
Find out more about the sources which are essential for our statistics
Lifetime risk estimates calculated by the Cancer Intelligence Team at Cancer Research UK 2023.
Sasieni PD, Shelton J, Ormiston-Smith N, et al. What is the lifetime risk of developing cancer?: The effect of adjusting for multiple primaries Br J Cancer, 2011.105(3): p.460-5
Brown KF, Rumgay H, Dunlop C, et al. The fraction of cancer attributable to known risk factors in England, Wales, Scotland, Northern Ireland, and the UK overall in 2015 British Journal of Cancer 2018.
International Agency for Research on Cancer. List of Classifications by cancer sites with sufficient or limited evidence in humans, Volumes 1 to 122. Accessed August 2018.
Brown KF, Rumgay H, Dunlop C, et al. The fraction of cancer attributable to known risk factors in England, Wales, Scotland, Northern Ireland, and the UK overall in 2015. British Journal of Cancer 2018.
Freedman ND, Silverman DT, Hollenbeck AR, et al. Association between smoking and risk of bladder cancer among men and women. JAMA. 2011 Aug 17;306(7):737-45.
Cumberbatch MG, Rota M, Catto JW,et al. The Role of Tobacco Smoke in Bladder and Kidney Carcinogenesis: A Comparison of Exposures and Meta-analysis of Incidence and Mortality Risks. Eur Urol. 2016 Sep;70(3):458-66.
van Osch FH, Jochems SH, van Schooten FJ, et al. Quantified relations between exposure to tobacco smoking and bladder cancer risk: a meta-analysis of 89 observational studies. Int J Epidemiol. 2016 Jun;45(3):857-70.
Hemelt M, Yamamoto H, Cheng KK, Zeegers MP. The effect of smoking on the male excess of bladder cancer: a meta-analysis and geographical analyses. Int J Cancer. 2009 Jan 15;124(2):412-9.
Brennan P, Bogillot O, Cordier S, et al. Cigarette smoking and bladder cancer in men: a pooled analysis of 11 case-control studies. Int J Cancer. 2000 Apr 15;86(2):289-94.
Brennan P, Bogillot O, Greiser E, et al. The contribution of cigarette smoking to bladder cancer in women (pooled European data). Cancer Causes Control. 2001 Jun;12(5):411-7.
't Mannetje A, Kogevinas M, Chang-Claude J, et al. Smoking as a confounder in case-control studies of occupational bladder cancer in women. Am J Ind Med. 1999 Jul;36(1):75-82.
International Agency for Research on Cancer. List of Classifications by cancer sites with sufficient or limited evidence in humans, Volumes 1 to 122. Accessed August 2018.
Brown KF, Rumgay H, Dunlop C, et al. The fraction of cancer attributable to known risk factors in England, Wales, Scotland, Northern Ireland, and the UK overall in 2015. British Journal of Cancer 2018.
Brown T, Slack R, Rushton L; British Occupational Cancer Burden Study Group. Occupational cancer in Britain. Urinary tract cancers: bladder and kidney. Br J Cancer. 2012 Jun 19;107 Suppl 1:S76-84.
't Mannetje A, Kogevinas M, Chang-Claude J, et al. Smoking as a confounder in case-control studies of occupational bladder cancer in women. Am J Ind Med. 1999 Jul;36(1):75-82.
Reulen RC, Kellen E, Buntinx F, et al. A meta-analysis on the association between bladder cancer and occupation. Scand J Urol Nephrol Suppl. 2008 Sep;(218):64-78.
Harling M, Schablon A, Schedlbauer G, et al. Bladder cancer among hairdressers: a meta- analysis. Occup Environ Med. 2010 May;67(5):351-8.
Takkouche B, Regueira-Méndez C, Montes-Martínez A. Risk of cancer among hairdressers and related workers: a meta-analysis. Int J Epidemiol. 2009 Dec;38(6):1512-31.
Rota M Bosetti C, Boccia S, et al. Occupational exposures to polycyclic aromatic hydrocarbons and respiratory and urinary tract cancers: an updated systematic review and a meta-analysis to 2014. Arch Toxicol. 2014 Aug;88(8):1479-90.
Manju L, George PS, Mathew A. Urinary bladder cancer risk among motor vehicle drivers: a meta-analysis of the evidence, 1977- 2008. Asian Pac J Cancer Prev. 2009 Apr-Jun;10(2):287-94.
Guha N, Steenland NK, Merletti F, et al. Bladder cancer risk in painters: a meta-analysis. Occup Environ Med 2010; 67(8):568-73.
International Agency for Research on Cancer. List of Classifications by cancer sites with sufficient or limited evidence in humans, Volumes 1 to 122. Accessed August 2018.
Brown KF, Rumgay H, Dunlop C, et al. The fraction of cancer attributable to known risk factors in England, Wales, Scotland, Northern Ireland, and the UK overall in 2015. British Journal of Cancer 2018.
Sawka AM, Thabane L, Parlea L, et al. Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: a systematic review and meta-analysis. Thyroid. 2009 May;19(5):451-7.
Frank C, Fallah M, Ji J, et al. The population impact of familial cancer, a major cause of cancer. Int J Cancer. 2014 Apr 15;134(8):1899-906.
Hemminki K, Bermejo JL, Ji J, Kumar R. Familial bladder cancer and the related genes. Curr Opin Urol. 2011 Sep;21(5):386-92.
International Agency for Research on Cancer. List of Classifications by cancer sites with sufficient or limited evidence in humans, Volumes 1 to 122. Accessed August 2018.
World Cancer Research Fund / American Institute for Cancer Research. Continuous Update Project Findings & Reports. Accessed September 2017.
Saint-Jacques N, Parker L, Brown P, Dummer TJ. Arsenic in drinking water and urinary tract cancers: a systematic review of 30 years of epidemiological evidence. Environ Health. 2014 Jun 2;13:44.
International Agency for Research on Cancer. Monographs on the evaluation of carcinogenic risks to humans, vol 100C. Arsenic and arsenic compounds Available from http://monographs.iarc.fr/ENG/Monographs/vol100C/. Accessed April 2014.
Tsuji JS, Alexander DD, Perez V, Mink PJ. Arsenic exposure and bladder cancer: quantitative assessment of studies in human populations to detect risks at low doses. Toxicology. 2014 Mar 20;317:17-30.
